Ansen, S., Bangard, C., Querings, S., Gabler, F., Scheffler, M., Seidel, D., et al. (2010). Osteoblastic response in patients with non-small cell lung cancer with activating EGFR mutations and bone metastases during treatment with EGFR kinase inhibitors. Journal of Thoracic Oncology, 5(3), 407-409. doi:10.1097/JTO.0b013e3181cf32aa.